» Articles » PMID: 36960050

Immune Damage Mechanisms of COVID-19 and Novel Strategies in Prevention and Control of Epidemic

Overview
Journal Front Immunol
Date 2023 Mar 24
PMID 36960050
Authors
Affiliations
Soon will be listed here.
Abstract

Caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), coronavirus disease 2019 (COVID-19) has diverse clinical manifestations, which is the main feature of the disease, and the fundamental reason is the different immune responses in different bodies among the population. The damage mechanisms of critical illness by SARS-CoV-2 and its variants, such as hyperinflammatory response, a double-edged function of type I interferon, and hyperactivation of the complement system, are the same as other critical illnesses. Targeting specific immune damage mechanisms of COVID-19, we scored the first to put forward that the responses of T cells induced by acute virus infection result in "acute T-cell exhaustion" in elderly patients, which is not only the peripheral exhaustion with quantity reduction and dysfunction of T cells but also the central exhaustion that central immune organs lost immune homeostasis over peripheral immune organs, whereas the increased thymic output could alleviate the severity and reduce the mortality of the disease with the help of medication. We discovered that immune responses raised by SARS-CoV-2 could also attack secondary lymphoid organs, such as the spleen, lymphoid nodes, and kidneys, in addition to the lung, which we generally recognize. Integrated with the knowledge of mechanisms of immune protection, we developed a coronavirus antigen diagnostic kit and therapeutic monoclonal antibody. In the future, we will further investigate the mechanisms of immune damage and protection raised by coronavirus infection to provide more scientific strategies for developing new vaccines and immunotherapies.

Citing Articles

Novel Oronasal Drainage for Long COVID: Proposed Mechanisms-Case Report.

Lorenz C, Frankenberger R Viruses. 2025; 17(2).

PMID: 40006965 PMC: 11861156. DOI: 10.3390/v17020210.


Age-related immune response disparities between adults and children with severe COVID-19: a case-control study in China.

Chen H, Li Y, Yuan L, Liu F, Sun Q, Luo Q Front Microbiol. 2025; 16:1525051.

PMID: 39967737 PMC: 11832681. DOI: 10.3389/fmicb.2025.1525051.


Quantitative IgG response to SARS-CoV-2 membrane protein in infected individuals strongly correlates with lung injury.

Faggioni G, Moramarco F, Luciano E, De Santis R, Amoroso A, Petralito G Sci Rep. 2024; 14(1):30665.

PMID: 39730423 PMC: 11681004. DOI: 10.1038/s41598-024-78381-8.


Phenotypic Timeline Kinetics, Integrative Networks, and Performance of T- and B-Cell Subsets Associated with Distinct Clinical Outcome of Severe COVID-19 Patients.

de Oliveira G, Costa-Rocha I, Oliveira-Carvalho N, Dos Santos T, Campi-Azevedo A, Peruhype-Magalhaes V Microorganisms. 2024; 12(11).

PMID: 39597661 PMC: 11596994. DOI: 10.3390/microorganisms12112272.


Case report: A rare case of malacoplakia resembling a malignant tumor of the cervix: a case report and review of the literature.

Li J, Mi J, Wang J, Zhuo Z Front Med (Lausanne). 2024; 11:1409239.

PMID: 38895183 PMC: 11183279. DOI: 10.3389/fmed.2024.1409239.


References
1.
Toldo S, Bussani R, Nuzzi V, Bonaventura A, Mauro A, Cannata A . Inflammasome formation in the lungs of patients with fatal COVID-19. Inflamm Res. 2020; 70(1):7-10. PMC: 7572246. DOI: 10.1007/s00011-020-01413-2. View

2.
Ferretti A, Kula T, Wang Y, Nguyen D, Weinheimer A, Dunlap G . Unbiased Screens Show CD8 T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein. Immunity. 2020; 53(5):1095-1107.e3. PMC: 7574860. DOI: 10.1016/j.immuni.2020.10.006. View

3.
Tao K, Tzou P, Nouhin J, Gupta R, de Oliveira T, Kosakovsky Pond S . The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. 2021; 22(12):757-773. PMC: 8447121. DOI: 10.1038/s41576-021-00408-x. View

4.
Sefik E, Qu R, Junqueira C, Kaffe E, Mirza H, Zhao J . Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 2022; 606(7914):585-593. PMC: 9288243. DOI: 10.1038/s41586-022-04802-1. View

5.
McMahan K, Yu J, Mercado N, Loos C, Tostanoski L, Chandrashekar A . Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. 2020; 590(7847):630-634. PMC: 7906955. DOI: 10.1038/s41586-020-03041-6. View